Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies

NCT04298892 is registered in ClinicalTrials.gov with Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS as lead sponsor.

NCT NCT04298892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04298892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
Lead sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase
Observational
Overall status
Unknown status
Start date
January 7, 2020
Completion date
February 28, 2025
Enrollment
2,000 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

haematologic disease, haematological malignancy